| 22204-53-1 |
| (S)-Naproxen |
| Naprosyn |
| (+)-Naproxen |
| Equiproxen |
| Naproxene |
| (S)-(+)-Naproxen |
| Naixan |
| d-Naproxen |
| Ec-Naprosyn |
| (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid |
| (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid |
| Laraflex |
| Naprosyne |
| Naproxeno |
| Nycopren |
| Calosen |
| Reuxen |
| Bonyl |
| Naxen |
| Axer |
| (+)-(S)-Naproxen |
| Naproxenum |
| Naprius |
| Veradol |
| Xenar |
| Dysmenalgit N |
| RS-3540 |
| Napren E |
| (S)-2-(6-Methoxy-2-naphthyl)propionic acid |
| (+)-2-(6-Methoxy-2-naphthyl)propionic acid |
| (+)-2-(Methoxy-2-naphthyl)-propionic acid |
| (S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid |
| d-2-(6-Methoxy-2-naphthyl)propionic acid |
| (S)-2-(6-Methoxy-2-naphthyl)propanoic acid |
| CG 3117 |
| (+)-2-(Methoxy-2-naphthyl)-propionsaeure |
| (+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid |
| NSC-750183 |
| NSC-757239 |
| 57Y76R9ATQ |
| CHEBI:7476 |
| DTXSID4040686 |
| (+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid |
| 2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (+)- |
| DTXCID2020686 |
| PN400 COMPONENT NAPROXEN |
| Apranax |
| Numidan |
| 2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (S)- |
| Methoxypropiocin |
| Stirlescent |
| Condrotec |
| Grenoxal |
| Kenosyn |
| Naprotin |
| Prosaid |
| Rimoxyn |
| Timpron |
| Naproxen oral |
| Napratec op |
| Feminax Ultra |
| Pranoxen continus |
| Naprosyn EC |
| Equiproxen Granules |
| Arthrosin 250 |
| Arthrosin 500 |
| Naproxen, Capsaicin |
| Naprosyn 375 |
| Rheuflex 250 |
| Rheuflex 500 |
| Trepoxen-250 |
| Arthrosin 250 ec |
| Arthrosin 500 ec |
| Timpron 250 ec |
| Timpron 500 ec |
| VALROX |
| EC-NAPROXEN |
| 6-methoxy-alpha-methyl-2-naphthaleneacetic acid |
| RefChem:6469 |
| Naproxen Delayed Release |
| Naproxen Oral Suspension |
| NAPROXEN,HISTIDINE |
| Equiproxen 10% Solution |
| G02CC02 |
| M01AE02 |
| M02AA12 |
| Sallus Pain Relief Collection With Naproxen |
| 244-838-7 |
| (2S)-2-(6-methoxynaphthalen-2-yl)propanoate |
| (S)-2-(6-methoxynaphthalen-2-yl)propanoic acid |
| Aleve |
| naproxen(+) |
| Acusprain |
| Anexopen |
| Arthrisil |
| Artrixen |
| Artroxen |
| Bipronyl |
| Clinosyn |
| Danaprox |
| Flexipen |
| Floginax |
| Leniartil |
| Novonaprox |
| Apronax |
| Artagen |
| Atiflan |
| Congex |
| Daprox |
| Genoxen |
| Lefaine |
| Nafasol |
| Nalyxan |
| Napflam |
| Napmel |
| Naposin |
| Napren |
| Fuxen |
| Naxyn |
| Apo-Naproxen |
| Anaprox |
| MFCD00010500 |
| Dysmenalgit |
| (2S)-2-(6-methoxy-2-naphthyl)propanoic acid |
| Apo-Napro-NA |
| Proxen |
| (alphas)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid |
| (S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid |
| CHEMBL154 |
| d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure |
| Propionic acid, 2-(6-methoxy-2-naphthyl)-, (+)- |
| Duk |
| 2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (S)- |
| Headlon |
| Napratec |
| Naprontag |
| Narocin |
| Naxopren |
| Prafena |
| Priaxen |
| Pronaxen |
| Rheumaflex |
| Saritilron |
| Sinartrin |
| Soproxen |
| Sutolin |
| Tohexen |
| Traumox |
| Flexen |
| Napxen |
| Noflam |
| Patxen |
| Rahsen |
| Sinton |
| Sutony |
| Velsay |
| Vinsen |
| Narma |
| Roxen |
| Anax |
| 2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (.alpha.S)- |
| CAS-22204-53-1 |
| Flanax Forte |
| Naprosyn LLE |
| Proxen LE |
| Naxen F |
| Proxen LLE |
| U-Ritis |
| Naprosyn LLE Forte |
| (S)-2-(6-Methoxy-naphthalen-2-yl)-propionic acid |
| Naproxi 250 |
| Naproxi 500 |
| (S)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid |
| aproxen |
| Naxyn 250 |
| Naxyn 500 |
| Naprosine |
| Equiproxen (Veterinary) |
| Mnpa |
| Naproxene [INN-French] |
| Naproxenum [INN-Latin] |
| Naproxeno [INN-Spanish] |
| Xenar-CR |
| CCRIS 5265 |
| HSDB 3369 |
| EINECS 244-838-7 |
| RS 3540 |
| UNII-57Y76R9ATQ |
| Naprolag |
| Naprosy |
| Panoxen |
| Proxine |
| SR-01000075977 |
| DL Naproxen |
| Naproxen CRS |
| Naprosyn (TN) |
| NPS |
| Prestwick_349 |
| (+)-2-(Methoxy-2-naphthyl)-propionsaeure [German] |
| Naproxen (Standard) |
| Naproxen [USAN:USP:INN:BAN:JAN] |
| d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure [German] |
| S-NAPROXEN |
| Spectrum_000977 |
| (R)-6-Methoxy-a-methyl-2-naphthaleneacetic acid |
| 4or0 |
| 4po0 |
| NAPROXEN [HSDB] |
| NAPROXEN [USAN] |
| (S)-(+)-Naproxene |
| NAPROXEN [INN] |
| NAPROXEN [JAN] |
| NAPROXEN [MI] |
| NAPROXEN [VANDF] |
| Prestwick0_000791 |
| Prestwick1_000791 |
| Prestwick2_000791 |
| Spectrum2_001043 |
| Spectrum3_000514 |
| Spectrum4_000069 |
| Spectrum5_001327 |
| (+)NAPROXEN |
| NAPROXEN [MART.] |
| Naproxen2-(6-Methoxy-naphthalen-2-yl)-propionic acid |
| Epitope ID:139974 |
| NAPROXEN [USP-RS] |
| NAPROXEN [WHO-DD] |
| UPCMLD-DP001 |
| 2-(6-Methoxy-naphthalen-2-yl)-propionic acid(Naproxen) |
| EC 244-838-7 |
| SCHEMBL3046 |
| Lopac0_000792 |
| BSPBio_002067 |
| KBioGR_000597 |
| KBioSS_001457 |
| BIDD:GT0062 |
| DivK1c_000242 |
| NAPROXEN [GREEN BOOK] |
| SPECTRUM1500425 |
| Naproxen (JP18/USP/INN) |
| Naproxen, 1mg/ml in Methanol |
| SPBio_000966 |
| SPBio_002861 |
| NAPROXEN [ORANGE BOOK] |
| GTPL5230 |
| orb1308096 |
| NAPROXEN [EP MONOGRAPH] |
| VIMOVO COMPONENT NAPROXEN |
| NAPROXEN [USP MONOGRAPH] |
| SCHEMBL29350704 |
| SCHEMBL29360045 |
| UPCMLD-DP001:001 |
| CMWTZPSULFXXJA-VIFPVBQESA- |
| HMS500M04 |
| KBio1_000242 |
| KBio2_001457 |
| KBio2_004025 |
| KBio2_006593 |
| KBio3_001567 |
| MSK7160 |
| Naproxen 1.0 mg/ml in Methanol |
| NINDS_000242 |
| GLXC-07868 |
| HMS1920P13 |
| HMS2089N21 |
| HMS2091H12 |
| HMS3649M13 |
| HMS3886C15 |
| Pharmakon1600-01500425 |
| NAPROXEN COMPONENT OF PN400 |
| Tox21_301953 |
| BDBM50339185 |
| CCG-40130 |
| EBC-03706 |
| HY-15030R |
| MSK7160-100A |
| NSC750183 |
| NSC757239 |
| AKOS005267223 |
| MSK7160-1000A |
| AC-1363 |
| DB00788 |
| FN26157 |
| ME-0100 |
| NSC 750183 |
| NSC 757239 |
| SDCCGSBI-0050769.P005 |
| IDI1_000242 |
| Naproxen 100 microg/mL in Acetonitrile |
| NCGC00016759-01 |
| NCGC00016759-02 |
| NCGC00016759-03 |
| NCGC00016759-29 |
| NCGC00016759-38 |
| NCGC00021127-01 |
| NCGC00161591-01 |
| NCGC00255562-01 |
| HY-15030 |
| SY015060 |
| Naproxen, meets USP testing specifications |
| SBI-0050769.P004 |
| M1021 |
| Naproxen Solution in Acetonitrile, 100ug/mL |
| NS00098611 |
| S5177 |
| Naproxen Solution in Acetonitrile, 1000ug/mL |
| Naproxen, VETRANAL(TM), analytical standard |
| (S)-2-(6-methoxy-2-naphthyl)-propionic acid |
| (S)-2-(6-methoxynaphthalen-2-yl)propanoicacid |
| C01517 |
| D00118 |
| EN300-139795 |
| O10203 |
| (2S)-2-(6-methoxy(2-naphthyl))propanoic acid |
| AB00052049-04 |
| AB00052049_05 |
| (+)(S)2-(6-methoxy-2-naphthyl)-propionic acid |
| (S)-6-Methoxy-?-methyl-2-naphthaleneacetic acid |
| 2-(6-Methoxy-2-naphthyl)propanoic acid , (+)- |
| F079426 |
| SR-01000003110 |
| Q-201447 |
| Q1215575 |
| SR-01000003110-5 |
| SR-01000075977-3 |
| SR-01000075977-4 |
| (+)-6-Methoxy-.alpha.-methyl-2-napthaleneacetic acid |
| (|_S)-6-Methoxy-|_-methyl-2-naphthaleneacetic acid |
| (|AS)-6-Methoxy-|A-methyl-2-naphthaleneacetic acid |
| BRD-K59197931-001-02-9 |
| BRD-K59197931-001-03-7 |
| BRD-K59197931-001-04-5 |
| BRD-K59197931-236-09-6 |
| BRD-K59197931-236-20-3 |
| BRD-K59197931-236-21-1 |
| BRD-K59197931-236-22-9 |
| SR-01000075977-10 |
| (+)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid |
| (S)-(+)-2-(6-methoxy-naphthalen-2-yl)-propionic acid |
| (S)-6-Methoxy-.alpha.-methyl-2-naphthalene acetic acid |
| Naproxen, British Pharmacopoeia (BP) Reference Standard |
| Naproxen, European Pharmacopoeia (EP) Reference Standard |
| Z1695772815 |
| (S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid, 98% |
| 2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (+)- |
| Naproxen, United States Pharmacopeia (USP) Reference Standard |
| (+)-(S)-6-METHOXY-.ALPHA.-METHYL-2-NAPHTHALENEACETIC ACID |
| Naproxen, Pharmaceutical Secondary Standard; Certified Reference Material |
| (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic Acid;(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic Acid |
| 131991-52-1 |
| InChI=1/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1 |
|
There are more than 10 synonyms. If you wish to see them all click here.
|
